Australian researchers have found insomnia patients using medicinal cannabis containing THC experience little or no next-day impairment in findings which could have a significant impact on the debate around drug-driving reform.
The team, including representatives from the Woolcock Institute of Medical Research and the Lambert Initiative for Cannabinoid Therapeutics, studied 20 adults with insomnia to determine next-day impairment following evening administration of a typical medicinal cannabis oil compared to a placebo.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.